Funded Tech Companies
Iterion Therapeutics
Looking for the VC firms that provided funding to Iterion Therapeutics? Venture Investors, Green Park & Golf Ventures and Viva Ventures Biotech joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Iterion Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2450 West Holcombe Blvd.
Houston, TX 77021
USA
Houston, TX 77021
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Iterion Therapeutics is a clinical stage biotechnology company developing novel cancer therapeutics. The company's lead product, Tegavivint, is unique among nuclear ß-catenin inhibitors in that it binds to TBL1 (Transducin ßeta-like Protein One), a novel downstream target in the Wnt-signaling pathway.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/17/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rahul Aras
Chief Medical Officer
Casey Cunningham
Chief Scientific Officer
Stephen Horrigan
VP - Operations
Rose Hernandez
VP - Regulatory Affairs
Gowri Sukumar
Company Investors
Browse more funded tech companies:
Iteratively | Itero Biopharmaceuticals
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs